Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP)

NCT01279694 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Melphalan
DRUG: Prednisone

Sponsor

Nantes University Hospital